(duplicate) Treatment of HE with UCL-L1V

• Research type

  Research Study

• Full title

  Multicentre, randomized, single-blind, placebo-controlled, ascending single-dose and repeat-dose study to evaluate the safety, pharmacokinetics, and pharmacodynamics of UCL-L1V (L-ornithine hydrochloride plus sodium phenylacetate) in the treatment of hyperammonemia in cirrhotic patients

• IRAS ID

  27877

• Contact name

  Rajiv Jalan

• Contact email

  r.jalan@ucl.ac.uk

• Eudract number

  2009-011772-29

• ISRCTN Number

  not issued

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  09/H0707/66

• Date of REC Opinion

  20 Aug 2009

• REC opinion

  Further Information Favourable Opinion